Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Benefit of phonemic cueing on confrontation naming in Alzheimer's disease.

Cerbone B, Massman PJ, Woods SP, York MK.

Clin Neuropsychol. 2019 Apr 29:1-16. doi: 10.1080/13854046.2019.1607904. [Epub ahead of print]

PMID:
31030619
2.

Reply: Heart Failure, Natriuretic Peptides, and Clinical Practice: Moving Beyond Binary.

Gupta DK, York MK, Wang TJ.

J Am Coll Cardiol. 2018 Sep 4;72(10):1180-1181. doi: 10.1016/j.jacc.2018.07.004. No abstract available.

3.

A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment.

Driskell LD, York MK, Heyn PC, Sanjak M, MacAdam C.

Arch Phys Med Rehabil. 2019 Mar;100(3):583-586. doi: 10.1016/j.apmr.2018.05.002. Epub 2018 Jul 17. No abstract available.

PMID:
30029769
4.

Restriction digest screening facilitates efficient detection of site-directed mutations introduced by CRISPR in C. albicans UME6.

Evans BA, Smith OL, Pickerill ES, York MK, Buenconsejo KJP, Chambers AE, Bernstein DA.

PeerJ. 2018 Jun 6;6:e4920. doi: 10.7717/peerj.4920. eCollection 2018.

5.

B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.

York MK, Gupta DK, Reynolds CF, Farber-Eger E, Wells QS, Bachmann KN, Xu M, Harrell FE Jr, Wang TJ.

J Am Coll Cardiol. 2018 May 15;71(19):2079-2088. doi: 10.1016/j.jacc.2018.02.071.

6.

Leg stereotypy syndrome: phenomenology and prevalence.

Lotia M, York MK, Strutt AM, Jankovic J.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):692-695. doi: 10.1136/jnnp-2017-317057. Epub 2018 Jan 13.

PMID:
29332008
7.

Performance Validity in Deep Brain Stimulation Candidates.

Rossetti MA, Collins RL, York MK.

Arch Clin Neuropsychol. 2018 Jun 1;33(4):508-514. doi: 10.1093/arclin/acx081.

PMID:
28961736
8.

Comparative Patient Satisfaction and Feasibility of a Pilot Parkinson's Disease Enrichment Program.

Choudhury TK, Harris C, Crist K, Satterwhite TK, York MK.

J Geriatr Psychiatry Neurol. 2017 Sep;30(5):253-260. doi: 10.1177/0891988717720299.

PMID:
28925334
9.
10.

Coping With Caregiver Burnout When Caring for a Person With Neurodegenerative Disease: A Guide for Caregivers.

Krishnan S, York MK, Backus D, Heyn PC.

Arch Phys Med Rehabil. 2017 Apr;98(4):805-807. doi: 10.1016/j.apmr.2016.11.002. Epub 2017 Feb 7. No abstract available.

PMID:
28185639
11.

Physical Activity Recommendations for the Aging Brain: A Clinician-Patient Guide.

Heyn PC, Hirsch MA, York MK, Backus D.

Arch Phys Med Rehabil. 2016 Jun;97(6):1045-7. doi: 10.1016/j.apmr.2016.02.003. Review. No abstract available.

PMID:
27233994
12.

Acute and Long-Term Effects of Multidirectional Treadmill Training on Gait and Balance in Parkinson Disease.

Bryant MS, Workman CD, Hou JG, Henson HK, York MK.

PM R. 2016 Dec;8(12):1151-1158. doi: 10.1016/j.pmrj.2016.05.001. Epub 2016 May 10.

PMID:
27178378
13.

Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.

Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D; CSP-468 Study Group.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):622-9. doi: 10.1136/jnnp-2014-308119. Epub 2014 Sep 2.

PMID:
25185211
14.

TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities.

Wiszniewski W, Hunter JV, Hanchard NA, Willer JR, Shaw C, Tian Q, Illner A, Wang X, Cheung SW, Patel A, Campbell IM, Gelowani V, Hixson P, Ester AR, Azamian MS, Potocki L, Zapata G, Hernandez PP, Ramocki MB, Santos-Cortez RL, Wang G, York MK, Justice MJ, Chu ZD, Bader PI, Omo-Griffith L, Madduri NS, Scharer G, Crawford HP, Yanatatsaneejit P, Eifert A, Kerr J, Bacino CA, Franklin AI, Goin-Kochel RP, Simpson G, Immken L, Haque ME, Stosic M, Williams MD, Morgan TM, Pruthi S, Omary R, Boyadjiev SA, Win KK, Thida A, Hurles M, Hibberd ML, Khor CC, Van Vinh Chau N, Gallagher TE, Mutirangura A, Stankiewicz P, Beaudet AL, Maletic-Savatic M, Rosenfeld JA, Shaffer LG, Davis EE, Belmont JW, Dunstan S, Simmons CP, Bonnen PE, Leal SM, Katsanis N, Lupski JR, Lalani SR.

Am J Hum Genet. 2013 Aug 8;93(2):197-210. doi: 10.1016/j.ajhg.2013.05.027. Epub 2013 Jun 27. Erratum in: Am J Hum Genet. 2013 Aug 8;93(2):405.

15.

Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis.

Strutt AM, Palcic J, Wager JG, Titus C, Macadam C, Brown J, Scott BM, Harati Y, Schulz PE, York MK.

ISRN Neurol. 2012;2012:912123. doi: 10.5402/2012/912123. Epub 2012 Jul 17.

16.

Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults.

Strutt AM, Ayanegui IG, Scott BM, Mahoney ML, York MK, San Miguel Montes LE.

Arch Clin Neuropsychol. 2012 Aug;27(5):545-56. doi: 10.1093/arclin/acs049. Epub 2012 Jun 12.

PMID:
22693138
17.

Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.

Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK.

Eur J Neurol. 2012 Dec;19(12):1525-31. doi: 10.1111/j.1468-1331.2012.03759.x. Epub 2012 May 26.

PMID:
22632922
18.

Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.

Armento ME, Stanley MA, Marsh L, Kunik ME, York MK, Bush AL, Calleo JS.

J Parkinsons Dis. 2012;2(2):135-51. doi: 10.3233/JPD-2012-12080. Review.

PMID:
23939438
19.

Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions.

Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK.

Parkinsons Dis. 2012;2012:512892. doi: 10.1155/2012/512892. Epub 2011 Nov 2. Erratum in: Parkinsons Dis. 2012;2012:907513.

20.

The Rey 15-item memory test and Spanish-speaking older adults.

Strutt AM, Scott BM, Shrestha S, York MK.

Clin Neuropsychol. 2011 Oct;25(7):1253-65. doi: 10.1080/13854046.2011.609839. Epub 2011 Sep 27.

PMID:
21951176
21.

The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Ha AD, Brown CH, York MK, Jankovic J.

Parkinsonism Relat Disord. 2011 Sep;17(8):625-8. doi: 10.1016/j.parkreldis.2011.05.020.

PMID:
21689962
22.

Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease.

Strutt AM, Simpson R, Jankovic J, York MK.

Eur J Neurol. 2012 Jan;19(1):121-7. doi: 10.1111/j.1468-1331.2011.03447.x. Epub 2011 Jun 11.

PMID:
21668586
23.

Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation.

Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK.

Parkinsonism Relat Disord. 2011 Jun;17(5):321-7. doi: 10.1016/j.parkreldis.2011.01.011. Epub 2011 Feb 11.

24.

Does apolipoprotein E genotype modify the clinical expression of ALS?

Jawaid A, Poon M, Strutt AM, Rice LK, McDowell EJ, Salamone AR, Qureshi SU, Simpson E, Appel SH, York MK, Schulz PE.

Eur J Neurol. 2011 Apr;18(4):618-24. doi: 10.1111/j.1468-1331.2010.03225.x. Epub 2010 Sep 28.

PMID:
20880000
25.

A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.

Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE.

Amyotroph Lateral Scler. 2010 Dec;11(6):542-8. doi: 10.3109/17482968.2010.482592. Epub 2010 May 26.

PMID:
20500116
26.

Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide.

Hannon PM, Kuo SH, Strutt AM, York MK, Kass JS.

Clin Neurol Neurosurg. 2010 Jul;112(6):544-7. doi: 10.1016/j.clineuro.2010.04.002. Epub 2010 May 4.

27.

Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).

Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS.

Amyotroph Lateral Scler. 2010 May 3;11(3):303-11. doi: 10.3109/17482961003727954.

PMID:
20433413
28.

Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis.

Lepow L, Van Sweringen J, Strutt AM, Jawaid A, MacAdam C, Harati Y, Schulz PE, York MK.

J Clin Exp Neuropsychol. 2010 Nov;32(9):913-22. doi: 10.1080/13803391003596439. Epub 2010 Apr 13.

PMID:
20390792
29.

Lumbar puncture alleviates chorea in a patient with Huntington's disease and normal pressure hydrocephalus.

Shirani P, Salamone AR, Lahijani E, York MK, Schulz PE.

Behav Neurol. 2009;21(3):193-5.

30.

Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center.

Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, Schulz PE.

Dement Geriatr Cogn Disord. 2010;29(1):28-36. doi: 10.1159/000254701. Epub 2010 Jan 27.

PMID:
20110698
31.

ALS disease onset may occur later in patients with pre-morbid diabetes mellitus.

Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE.

Eur J Neurol. 2010 May;17(5):733-9. doi: 10.1111/j.1468-1331.2009.02923.x. Epub 2010 Jan 13.

PMID:
20074230
32.

Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location.

York MK, Wilde EA, Simpson R, Jankovic J.

J Neurol Sci. 2009 Dec 15;287(1-2):159-71. doi: 10.1016/j.jns.2009.08.003. Epub 2009 Sep 19.

33.

Ethnic disparities in the treatment of dementia in veterans.

Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, Schulz PE.

Dement Geriatr Cogn Disord. 2009;28(2):145-52. doi: 10.1159/000235577. Epub 2009 Aug 18.

PMID:
19690417
34.

Predictors of individual visual memory decline after unilateral anterior temporal lobe resection.

Dulay MF, Levin HS, York MK, Mizrahi EM, Verma A, Goldsmith I, Grossman RG, Yoshor D.

Neurology. 2009 May 26;72(21):1837-42. doi: 10.1212/WNL.0b013e3181a71132.

PMID:
19470966
35.

Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease.

Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, York MK.

J Neuropsychiatry Clin Neurosci. 2008 Summer;20(3):357-63. doi: 10.1176/appi.neuropsych.20.3.357.

PMID:
18806240
36.

Changes in individual and group spatial and verbal learning characteristics after anterior temporal lobectomy.

Dulay MF, Levin HS, York MK, Li X, Mizrahi EM, Goldsmith I, Verma A, Goldman A, Grossman RG, Yoshor D.

Epilepsia. 2009 Jun;50(6):1385-95. doi: 10.1111/j.1528-1167.2008.01730.x. Epub 2008 Jul 24.

37.

Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.

Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, Grossman RG, York MK.

Surg Neurol. 2009 May;71(5):551-8. doi: 10.1016/j.surneu.2008.03.039. Epub 2008 Jun 2.

38.

Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.

York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J.

J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):789-95. Epub 2007 Oct 26.

PMID:
17965146
39.

Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.

York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, Grossman RG.

Acta Neurochir (Wien). 2007;149(9):857-66; discussion 866. Epub 2007 Jul 12.

PMID:
17624489
40.

Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures.

Dulay MF, York MK, Soety EM, Hamilton WJ, Mizrahi EM, Goldsmith IL, Verma A, Grossman RG, Yoshor D, Armstrong DD, Levin HS.

Epilepsia. 2006 Nov;47(11):1922-30.

41.

The neural substrates of reward processing in humans: the modern role of FMRI.

McClure SM, York MK, Montague PR.

Neuroscientist. 2004 Jun;10(3):260-8. Review.

PMID:
15155064
42.
43.

Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease.

York MK, Levin HS, Grossman RG, Lai EC, Krauss JK.

J Clin Exp Neuropsychol. 2003 Feb;25(1):110-21.

PMID:
12607176
44.

Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals.

York MK, Franks JJ, Henry RR, Hamilton WJ.

Psychol Med. 2001 Oct;31(7):1279-91.

PMID:
11681554
45.

Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood.

Fuller DD, Davis TE Jr, Denys GA, York MK.

J Clin Microbiol. 2001 Aug;39(8):2933-6.

46.

Pallidotomy and psychological outcomes.

York MK, Levin HS, Grossman RG.

J Neurosurg. 2001 May;94(5):866-8. No abstract available.

PMID:
11354429
47.

Multilaboratory validation of rapid spot tests for identification of Escherichia coli.

York MK, Baron EJ, Clarridge JE, Thomson RB, Weinstein MP.

J Clin Microbiol. 2000 Sep;38(9):3394-8.

48.

Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease.

Rettig GM, York MK, Lai EC, Jankovic J, Krauss JK, Grossman RG, Levin HS.

J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):326-36.

49.

Evaluation of a combination rapid immunoassay for detection of Giardia and Cryptosporidium antigens.

Chan R, Chen J, York MK, Setijono N, Kaplan RL, Graham F, Tanowitz HB.

J Clin Microbiol. 2000 Jan;38(1):393-4.

50.

Neuropsychological outcome following unilateral pallidotomy.

York MK, Levin HS, Grossman RG, Hamilton WJ.

Brain. 1999 Dec;122 ( Pt 12):2209-20. Review.

PMID:
10581217

Supplemental Content

Support Center